Body mass index and atrial fibrillation recurrence post ablation: A systematic review and dose-response meta-analysis
Frontiers in Cardiovascular Medicine · 02.02.2023 · 9
DOI: 10.3389/fcvm.2022.999845 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 02.02.2023. Verfasst von Fuwei Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Affiliated Ganzhou Hospital of Nanchang University, Ganzhou, Jiangxi, China. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
The aim of this study was to evaluate the shape of the dose-response relationship between body mass index (BMI) and atrial fibrillation (AF) recurrence in patients who have undergone radiofrequency ablation.
Methods
Studies investigating BMI and AF recurrence in patients with AF after ablation were identified through electronic searches in the PubMed, EMBASE, and Cochrane Library databases. The potential non-linear relationship was fitted using robust error meta-regression. Our study was registered with PROSPERO (CRD42019121373).
Results
Twenty-six cohort studies with 7,878 cases/26,450 individuals were included, and a linear dose-response relationship between BMI and AF recurrence ( P non–linearity = 0.12) was found. The risk of AF recurrence in patients with a BMI over 28 was significantly increased. Specifically, for each 5 kg/m 2 increase in BMI, the risk of AF recurrence increased by 15% (95% CI: 1.08–1.22) with moderate heterogeneity ( I 2 = 53%). Subgroup analyses showed that the pooled risk ratio was not significantly changed in subgroup analysis adjustment for the following important potential intermediate factors: left atrial diameter and obstructive sleep apnea.
Conclusion
This study showed that there is a borderline positive linear association between BMI and AF recurrence post ablation. Overweight and obesity are significantly associated with AF recurrence. Systematic review registration https://www.crd.york.ac.uk/PROSPERO/ , identifier CRD42019128770.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, The Affiliated Ganzhou Hospital of Nanchang University, Ganzhou, Jiangxi, China.
- Department of Endocrine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
- Department of Cardiology, The First People's Hospital of Yulin, Yulin, Guangxi, China.
- Department of Anesthesia, The Third People's Hospital of Nanchang, Nanchang, Jiangxi, China.
- Department of Pharmacology and Systems Physiology, University of Cincinnati College of Medicine, Cincinnati, OH, United States.
Zitieren
APA
Liu, F., Song, T., Hu, Q., Zhu, X., Zhao, H., Tan, Z., Yu, P., Ma, J., Luo, J., & Liu, X. (2023). Body mass index and atrial fibrillation recurrence post ablation: A systematic review and dose-response meta-analysis. Frontiers in Cardiovascular Medicine, 9. https://doi.org/10.3389/fcvm.2022.999845
Vancouver
Liu F, Song T, Hu Q, Zhu X, Zhao H, Tan Z, et al. Body mass index and atrial fibrillation recurrence post ablation: A systematic review and dose-response meta-analysis. Frontiers in Cardiovascular Medicine. 2023;9. doi:10.3389/fcvm.2022.999845
BibTeX
@article{Liu2023,
author = {Liu, Fuwei and Song, Tiangang and Hu, Qingwen and Zhu, Xin and Zhao, Huilei and Tan, Ziqi and Yu, Peng and Ma, Jianyong and Luo, Jun and Liu, Xiao},
title = {Body mass index and atrial fibrillation recurrence post ablation: A systematic review and dose-response meta-analysis},
journal = {Frontiers in Cardiovascular Medicine},
year = {2023},
volume = {9},
doi = {10.3389/fcvm.2022.999845}
}
EUVIMED